These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 15065884

  • 1. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
    Li J, Melvin WS, Tsai MD, Muscarella P.
    Biochemistry; 2004 Apr 13; 43(14):4394-9. PubMed ID: 15065884
    [Abstract] [Full Text] [Related]

  • 2. Dissection of CDK4-binding and transactivation activities of p34(SEI-1) and comparison between functions of p34(SEI-1) and p16(INK4A).
    Li J, Muscarella P, Joo SH, Knobloch TJ, Melvin WS, Weghorst CM, Tsai MD.
    Biochemistry; 2005 Oct 11; 44(40):13246-56. PubMed ID: 16201750
    [Abstract] [Full Text] [Related]

  • 3. Direct binding of the N-terminus of HTLV-1 tax oncoprotein to cyclin-dependent kinase 4 is a dominant path to stimulate the kinase activity.
    Li J, Li H, Tsai MD.
    Biochemistry; 2003 Jun 10; 42(22):6921-8. PubMed ID: 12779347
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R, Laín S, Ball KL, Lane DP.
    Oncogene; 1998 Feb 05; 16(5):587-96. PubMed ID: 9482104
    [Abstract] [Full Text] [Related]

  • 5. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE, Xiong Y.
    Cell Growth Differ; 1998 Aug 05; 9(8):595-610. PubMed ID: 9716177
    [Abstract] [Full Text] [Related]

  • 6. Identification of functional elements of p18INK4C essential for binding and inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.
    Noh SJ, Li Y, Xiong Y, Guan KL.
    Cancer Res; 1999 Feb 01; 59(3):558-64. PubMed ID: 9973200
    [Abstract] [Full Text] [Related]

  • 7. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).
    Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson IN, Shimamoto A, Furuichi Y, Okumura K, Niwa S, Taya Y, Hara E.
    Genes Dev; 1999 Nov 15; 13(22):3027-33. PubMed ID: 10580009
    [Abstract] [Full Text] [Related]

  • 8. Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity.
    Reynaud EG, Guillier M, Leibovitch MP, Leibovitch SA.
    Oncogene; 2000 Feb 24; 19(9):1147-52. PubMed ID: 10713702
    [Abstract] [Full Text] [Related]

  • 9. Two different bindings of p21 Cdk inhibitor to cyclin/Cdk complex.
    Nakanishi M, Kagawa Y, Takahashi H, Matsushime H.
    Leukemia; 1997 Apr 24; 11 Suppl 3():356-7. PubMed ID: 9209388
    [Abstract] [Full Text] [Related]

  • 10. HTLV-1 Tax protein interacts with cyclin-dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4.
    Suzuki T, Kitao S, Matsushime H, Yoshida M.
    EMBO J; 1996 Apr 01; 15(7):1607-14. PubMed ID: 8612584
    [Abstract] [Full Text] [Related]

  • 11. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms.
    Suzuki T, Narita T, Uchida-Toita M, Yoshida M.
    Virology; 1999 Jul 05; 259(2):384-91. PubMed ID: 10388662
    [Abstract] [Full Text] [Related]

  • 12. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK, Moraes RC, Singh U, Kittrell FS, Medina D.
    Cell Growth Differ; 2001 Jun 05; 12(6):285-95. PubMed ID: 11432803
    [Abstract] [Full Text] [Related]

  • 13. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
    Bessa M, Saville MK, Watson RJ.
    Oncogene; 2001 Jun 07; 20(26):3376-86. PubMed ID: 11423988
    [Abstract] [Full Text] [Related]

  • 15. Solution structure of p21(Waf1/Cip1/Sdi1) C-terminal domain bound to Cdk4.
    Sung YH, Shin J, Shin J, Lee W.
    J Biomol Struct Dyn; 2001 Dec 07; 19(3):419-27. PubMed ID: 11790141
    [Abstract] [Full Text] [Related]

  • 16. An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.
    Li J, Joo SH, Tsai MD.
    Biochemistry; 2003 Nov 25; 42(46):13476-83. PubMed ID: 14621993
    [Abstract] [Full Text] [Related]

  • 17. p34SEI-1 inhibits apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein: p34SEI-1 as a novel target for anti-breast cancer strategies.
    Hong SW, Kim CJ, Park WS, Shin JS, Lee SD, Ko SG, Jung SI, Park IC, An SK, Lee WK, Lee WJ, Jin DH, Lee MS.
    Cancer Res; 2009 Feb 01; 69(3):741-6. PubMed ID: 19176394
    [Abstract] [Full Text] [Related]

  • 18. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
    Calbó J, Serna C, Garriga J, Graña X, Mazo A.
    Cell Death Differ; 2004 Oct 01; 11(10):1055-65. PubMed ID: 15309028
    [Abstract] [Full Text] [Related]

  • 19. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun 01; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 20. Tumor suppressor INK4: determination of the solution structure of p18INK4C and demonstration of the functional significance of loops in p18INK4C and p16INK4A.
    Li J, Byeon IJ, Ericson K, Poi MJ, O'Maille P, Selby T, Tsai MD.
    Biochemistry; 1999 Mar 09; 38(10):2930-40. PubMed ID: 10074345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.